‘Bone metastases’
Characterization of Novel Drugs that Target the Hedgehog Signaling Pathway in Tumor Induced Bone Disease
This research presents information about optimized transfection conditions for MDA-MB- 231 cells, as well as cell viability data on known antagonists.
Posted by Greta Clinton-Selin on Wednesday, April 29th, 2015 in May 2015, Bone metastases, Gli2, Hedgehog Signaling Pathway